$ABUS Vaccines with Arbutus’ intellectual property, their LNPs, are already in Phase 2/3 trials & will be given EUA (emergency use approval) before the end of the year, maybe sooner. EARNINGS REPORT confirmed their stake in Genevant and their royalty T.B.A SOON. $ABUS SOON TO Receiving Royalties from the Sale of 100’s of Millions, POSSIIBLE Billions of Vaccines.